Transferon Oral® reduces IgE levels and cellular infiltration in NALT in a murine model of allergic rhinitis
Revista Alergia México · 2025
DOI: 10.29262/ram.v72i3.1512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Alergia México, 2025. Verfasst von Ismael Trejo-Martínez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Desarrollo e Investigación en Bioterapéuticos (UDIBI), Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, CDMX, Méxic…. Hauptthemen laut MEDLINE: Immunoglobulin E, Rhinitis, Allergic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Allergic rhinitis (AR) affects the quality of life of 400 million patients worldwide, and while the pharmacological treatment options are extensive, more effective and safer treatments continue to be developed. The immunomodulator Transferon Oral® (TO) improves the clinical presentation of patients with AR; however, the immunological mechanisms by which it exerts its therapeutic effect are under investigation. This study aimed to develop an ovalbumin (OVA)-induced AR murine model. AR was established in female BALB/c mice (5-8 weeks old) by intraperitoneal inoculation of 200 μL of OVA (1 mg/mL)/Al(OH)3 (1.3%) on days 0, 1, 2, 7, 8, 14 and 21, and subsequently stimulated daily intranasally (RIN) with 20 μL of OVA (1 mg/mL) until day 42. The establishment of RA was evidenced by the increase in serum IgE against OVA by ELISA (OD > 0.5) and clinical signs. Subsequently, the effect of TO (0.75 μg) orally and dexamethasone (Dexa; 125 μg) intraperitoneally was evaluated in RA mice (n=6) for 21 days with daily RIN. TO significantly decreased specific IgE levels (p < 0.0001) at 7 and 14 days of treatment, while Dexa did so until day 14 (p < 0.0001) compared to the RA control group. Additionally, an analysis showed that TO reduced basal lamina thickness and decreased eosinophil and mast cell infiltration in NALT compared with RA controls. This work demonstrates that TO modulates the core RA molecule, IgE, and cell migration in NALT, and is the first step toward understanding its mechanism of action in this disease. Keywords: Dialyzable leukocyte extract; Oral transferon; Immunomodulators; Allergic rhinitis; Oral peptides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Desarrollo e Investigación en Bioterapéuticos (UDIBI), Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, CDMX, México.
- Laboratorio Nacional para Servicios Especializados de Investigación, Desarrollo e Innovación (I + D + i) para Farmoquímicos y Biotecnológicos (LANSEIDI-FarBiotec-CONACyT), CDMX, México.
- Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, CDMX, México.
- Laboratorio de Psicoinmunología, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, CDMX, México.
- Laboratorio de filogenia del sistema inmune de piel y mucosas, Departamento de Biología Celular y Tisular, Facultad de Medicina, Universidad Nacional Autónoma de México, CDMX, México.
- Laboratorio Nacional para Servicios Especializados de Investigación, Desarrollo e Innovación (I + D + i) para Farmoquímicos y Biotecnológicos (LANSEIDI-FarBiotec-CONACyT), CDMX, México. lavallejos@ipn.mx.
Zitieren
APA
Trejo-Martínez, I., Fragozo, A., Mendoza-Salazar, I., Pavón, L., Pérez-Torres, A., Vallejo-Castillo, L., & Pérez-Tapia, S. M. (2025). Transferon Oral® reduces IgE levels and cellular infiltration in NALT in a murine model of allergic rhinitis. Revista Alergia México. https://doi.org/10.29262/ram.v72i3.1512
Vancouver
Trejo-Martínez I, Fragozo A, Mendoza-Salazar I, Pavón L, Pérez-Torres A, Vallejo-Castillo L, et al. Transferon Oral® reduces IgE levels and cellular infiltration in NALT in a murine model of allergic rhinitis. Revista Alergia México. 2025. doi:10.29262/ram.v72i3.1512
BibTeX
@article{TrejoMartnez2025,
author = {Trejo-Martínez, Ismael and Fragozo, Ana and Mendoza-Salazar, Ivette and Pavón, Lenin and Pérez-Torres, Armando and Vallejo-Castillo, Luis and Pérez-Tapia, Sonia Mayra},
title = {Transferon Oral® reduces IgE levels and cellular infiltration in NALT in a murine model of allergic rhinitis},
journal = {Revista Alergia México},
year = {2025},
doi = {10.29262/ram.v72i3.1512}
}
EUVIMED